Myriad Closes Private Placement

Rhea-AI Summary

Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) has successfully closed a non-brokered private placement, raising $761,800 through the issuance of 5,078,666 units at a price of $0.15 per unit. Each unit consists of one common share and one-half of one share purchase warrant, with each full warrant entitling the holder to purchase one common share at an exercise price of $0.25 until June 15, 2025. The Company will use the proceeds for general working capital. The Financing is subject to a four month hold period in accordance with applicable Canadian securities laws, which expires April 16, 2024. Directors and officers of the Company participated in the Financing, exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of such participation does not exceed 25% of the market capitalization of the Company.

Vancouver, British Columbia--(Newsfile Corp. - December 15, 2023) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement (the "Financing"), raising gross proceeds of $761,800 through the issuance of 5,078,666 units at a price of $0.15 per unit. Each unit consists of one common share and one-half of one share purchase warrant, with each full warrant entitling the holder to purchase one common share at an exercise price of $0.25 until June 15, 2025. The Company will use the proceeds of the Financing for general working capital.

The Company paid aggregate finder's fees of $19,740 in connection with the Financing and issued an aggregate of 131,600 finder's warrants. Each finder's warrant entitles the holder to purchase one common share at an exercise price of $0.15 until June 15, 2025. Securities issued under the Financing are subject to a four month hold period in accordance with applicable Canadian securities laws, which expires April 16, 2024.

Directors and officers of the Company participated in Financing, and such participation is considered to be a "related party transaction" as defined under Multilateral Instrument 61-101 ("MI 61-101"). This is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of such participation does not exceed 25% of the market capitalization of the Company, as determined in accordance with MI 61-101.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release in the United States. Such securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or "U.S. Persons", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

About Myriad Uranium Corp.

Myriad Uranium Corp. is a uranium exploration company with an earnable 75% interest in the 1,911 acre Copper Mountain Uranium Project in Wyoming, USA. Copper Mountain hosts several known uranium deposits and historic uranium mines, including the Arrowhead Mine which produced 500,000 lbs of eU₃O₈. Copper Mountain saw extensive drilling and development by Rocky Mountain Energy, a subsidiary of Union Pacific, which developed a mine plan and built a leach pad for one of the deposits at Copper Mountain. Operations ceased in 1980 before mining could commence due to falling uranium prices. Approximately 2,000 boreholes have been drilled at Copper Mountain and the project area has significant exploration upside. Rocky Mountain Energy is estimated to have spent US$74 million (2023 dollars) exploring and developing Copper Mountain, generating significant historical resource estimates which are detailed here.

Myriad also holds 80% ownership of over 1,800 km² of uranium exploration licenses in the Tim Mersoï Basin, Niger, and the option to earn up to 100%. These licenses are surrounded by many of the most significant uranium deposits in Africa, including Orano's 384 Mlbs eU₃O₈ Imouraren, Global Atomic's 236 Mlbs Dasa, and Goviex's 100 Mlbs Madaouela, and on the same fault structures. Myriad also has a 50% interest in the Millen Mountain Property in Nova Scotia, Canada, with the other 50% held by Probe Metals Inc. For further information, please refer to Myriad's disclosure record on SEDAR+ (www.sedarplus.ca), contact Myriad by telephone at +1.604.418.2877, or refer to Myriad's website at www.myriaduranium.com.

A recent interview with Crux Investors is here. A video overview of the Copper Mountain Project is here. The Company's factsheet is here.

Myriad Contacts:
Thomas Lamb
President and CEO
tlamb@myriaduranium.com

Forward-Looking Statements

Mineralization hosted on adjacent or nearby properties is not necessarily indicative of mineralization hosted on the Company's properties. This news release contains "forward-looking information" that is based on the Company's current expectations, estimates, forecasts and projections. This forward-looking information includes, among other things, the Company's business, plans, outlook and business strategy. The words "may", "would", "could", "should", "will", "likely", "expect," "anticipate," "intend", "estimate", "plan", "forecast", "project" and "believe" or other similar words and phrases are intended to identify forward-looking information. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect, including with respect to the Company's business plans respecting the exploration and development of the Company's mineral properties, the proposed work program on the Company's mineral properties and the potential and economic viability of the Company's mineral properties. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include, but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.

The CSE has not reviewed, approved or disapproved the contents of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/191294

FAQ

What is the recent announcement from Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q)?

Myriad Uranium Corp. has successfully closed a non-brokered private placement, raising $761,800 through the issuance of 5,078,666 units at a price of $0.15 per unit.

How will the proceeds from the Financing be utilized by Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q)?

The Company will use the proceeds of the Financing for general working capital.

What is the hold period for the securities issued under the Financing by Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q)?

Securities issued under the Financing are subject to a four month hold period in accordance with applicable Canadian securities laws, which expires April 16, 2024.

What is the participation of directors and officers in the Financing by Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q)?

Directors and officers of the Company participated in the Financing, exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of such participation does not exceed 25% of the market capitalization of the Company.